Herbas VPB

Print
EN | LT
LT - Nauji izoksazolinai ir izoksazolo fibrinogeno receptoriaus antagonistai
EN - NOVEL ISOXAZOLINE AND ISOXAZOLE FIBRINOGEN RECEPTOR ANTAGONISTS

Legal status

Patent lapsed (non-payment of fees)

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL.: (2006.01) A61K 31/42
A61K 31/423
A61K 31/435
A61K 31/445
A61K 31/495
A61K 31/496
A61K 31/535
A61K 31/5375
A61K 31/55
A61K 45/00
A61P 1/00
A61P 3/00
A61P 7/00
A61P 9/00
A61P 11/00
A61P 17/00
A61P 19/00
A61P 27/00
A61P 29/00
A61P 31/00
A61P 35/00
A61P 37/00
A61P 43/00
C07D 261/00
C07D 413/00
C07D 498/00
Patent
(11) Number of the document 4416
(13) Kind of document B
(21) Application number 97-182
(22) Date of filing the application 1997-11-24
(41) Date of publication of the application 1998-07-27
(45) Date of publication of patent 1998-12-28
PCT application
(86) Number PCT/US96/07692
Date 1996-05-30
PCT application publication
(87) Number WO 96/38426
Date 1996-12-05
Priority applications
(30) Number Date Country code
455436 1995-05-31 US
Applicant
(71) THE DU PONT MERCK PHARMACEUTICAL COMPANY, 1007 Market Street, Wilmington, Delaware 19898, US
Inventors
(72) John WITYAK, US
Gary Avonn CAIN, US
Douglas Guy BATT, US
Donald PINTO, US
Munir Alwan HUSSAIN, US
Chu Biao XUE, US
Thais Motria SIELECKI-DZURDZ, US
Richard Eric OLSON, US
William Frank DEGRADO, US
Shaker Ahmed MOUSA, US
Grantee
(73) BRISTOL-MYERS SQUIBB PHARMA COMPANY, Route 206 & Provinceline Road, Princeton, New Jersey 08543-4000, US
Attorney or representative
(74) Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT
Title
(54) NOVEL ISOXAZOLINE AND ISOXAZOLE FIBRINOGEN RECEPTOR ANTAGONISTS
Last renewal fee
Payment date Validity (years) Amount
2002-04-08 7 560.00 LTL
Legal status
Patent lapsed (non-payment of fees)
Invalidation date 2003-05-30